Diarrhea is the second most common side effect of tirzepatide in its weight trials, after nausea.
Constipation shows up on the same drugs, and the two can be linked. A 2025 nutrition advisory notes that long-lasting constipation can itself lead to diarrhea [5]. Here is what the label counted and what guidance suggests. The full side effect record is in tirzepatide side effects.
How often does it happen?
The Zepbound label pools its two main weight trials [1]. The diarrhea row also counts frequent bowel movements.
| Drug and dose | Drug group | Placebo |
|---|---|---|
| Tirzepatide 5 mg weekly | 19% | 8% |
| Tirzepatide 10 mg weekly | 21% | 8% |
| Tirzepatide 15 mg weekly | 23% | 8% |
| Semaglutide 2.4 mg weekly | 30% | 16% |
The semaglutide row is from the Wegovy label’s own trials [2]. Different trials enrolled different people, so the two drugs are not compared head to head here.
Across all stomach and bowel effects, 56% on each tirzepatide dose reported one, against 30% on placebo [1]. Stopping for them rose with dose: 1.9%, 3.3% and 4.3%, against 0.5% on placebo.
When it starts and how long it lasts
The label says most nausea, vomiting and diarrhea came during dose escalation and decreased over time [1]. Each dose step is at least 4 weeks apart, as laid out in tirzepatide dosage.
A multidisciplinary consensus paper describes GLP-1 drugs as a class [3]. It reports diarrhea starts in the first 4 weeks and then drops off. In people with obesity, symptoms lasted about 3 days.
That paper also notes something useful about longer-acting drugs. They were linked to less nausea but more diarrhea, possibly from a steadier effect on the gut.
How many people needed medicine for it?
A pooled analysis of SURMOUNT-1 to -4 tracked this [4]. In SURMOUNT-1 to -3, 5.2% to 9.3% on tirzepatide used one anti-diarrheal medicine, against 1.2% to 2.2% on placebo.
First use was most common in the first 24 weeks, which covered the dose increases. At most 0.3% used two anti-diarrheal products at once.
The same analysis found weight loss was similar with or without nausea, vomiting or diarrhea. Counting indigestion too, these effects accounted for up to 3.1% of the total weight reduction.
What the guidance suggests
These are expert recommendations, not tested treatments. Fluids come first in both.
The consensus paper lists generous hydration [3]. It suggests avoiding dairy, coffee, alcohol, soft drinks and very hot or cold food while diarrhea lasts.
It also flags sweeteners ending in “-ol,” such as sorbitol and xylitol, in gum and candy. It suggests cutting back on high-fiber food for a while, then adding it back once symptoms ease.
Its gentler list includes chicken broth, rice, carrots and very ripe fruit without the skin.
The nutrition advisory adds avoiding large or high-fat meals [5]. If diarrhea is significant, it says fiber capsules or powders can bulk the stool, and anti-diarrheal medicine can give short-term relief.
When it is more than routine
The main risk is losing fluid. The Zepbound label warns that dehydration from diarrhea, nausea or vomiting can cause kidney problems [1].
It tells you to drink fluids and to report diarrhea that does not go away. The advisory adds that dehydration can also bring heart palpitations [5].
In a worked case of 4 to 5 episodes a day, the consensus paper’s first step was to rule out infection and inflammation [3]. It names probiotics or loperamide if symptoms persist despite the steps above.
Related reading
Nausea on the same class of drug is covered in Ozempic nausea. The other bowel problem is in semaglutide constipation.
How soon tirzepatide starts working is covered in how long it takes for tirzepatide to work. To compare prescribers, see the compounded tirzepatide rankings.